Trials / Unknown
UnknownNCT05671744
Fetal Cell Analysis From Maternal Blood
Validation of a Cell-Based Technology for Non-Invasive-Prenatal-Diagnosis (CB-NIPD) Using Circulating Whole Fetal Cells From Maternal Peripheral Blood.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,500 (estimated)
- Sponsor
- Menarini Biomarkers Singapore · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this clinical study is the evaluation of clinical performance of a cell-based non-invasive test technology for fetal aneuploidies and segmental imbalances detection in a high-risk pregnancies population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cell-based non-invasive prenatal testing | Blood sampling |
Timeline
- Start date
- 2021-11-22
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
- First posted
- 2023-01-05
- Last updated
- 2023-01-05
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05671744. Inclusion in this directory is not an endorsement.